Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying
Superadmin
0
0
Half of U.S. employers and health plans are balking at paying for GLP-1 drugs like Ozempic, Zepbound and Wegovy for weight loss and obesity treatment, a new report shows.
